Hence, B cell lymphoma cells may benefit from acquired N-glycan motifs in their BCR by receiving sustained BCR activation via environmental mannose-binding lectins, as well as by the dark zone signature that is associated with this phenotype. The gene discussed is BCR; the disease is B-cell non-Hodgkin lymphoma.